![Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study) | The BMJ Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study) | The BMJ](https://www.bmj.com/content/bmj/338/bmj.b1542/F1.large.jpg)
Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study) | The BMJ
![Mean Psoriasis Area and Severity Index (PASI) score in patients treated... | Download Scientific Diagram Mean Psoriasis Area and Severity Index (PASI) score in patients treated... | Download Scientific Diagram](https://www.researchgate.net/publication/23466796/figure/fig2/AS:293870556069889@1447075608680/Mean-Psoriasis-Area-and-Severity-Index-PASI-score-in-patients-treated-with.png)
Mean Psoriasis Area and Severity Index (PASI) score in patients treated... | Download Scientific Diagram
![PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/45/7/922/F3.large.jpg)
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology
![A) Mean Psoriasis Area and Severity Index (PASI) scores 9 in patients... | Download Scientific Diagram A) Mean Psoriasis Area and Severity Index (PASI) scores 9 in patients... | Download Scientific Diagram](https://www.researchgate.net/publication/308763667/figure/fig2/AS:560652386095105@1510681353836/A-Mean-Psoriasis-Area-and-Severity-Index-PASI-scores-9-in-patients-with-psoriasis_Q320.jpg)
A) Mean Psoriasis Area and Severity Index (PASI) scores 9 in patients... | Download Scientific Diagram
![Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis](https://www.jhrr.org/articles/2018/5/2/images/JHealthResRev_2018_5_2_86_238863_f1.jpg)
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis
![Training on the Modular Approach on the assessment and management of psoriatic arthritis (PsA) for dermatology units This PsA Assessment initiative is. - ppt download Training on the Modular Approach on the assessment and management of psoriatic arthritis (PsA) for dermatology units This PsA Assessment initiative is. - ppt download](https://slideplayer.com/slide/13847028/85/images/25/Psoriasis+Area+Severity+Index+%28PASI%29.jpg)
Training on the Modular Approach on the assessment and management of psoriatic arthritis (PsA) for dermatology units This PsA Assessment initiative is. - ppt download
![Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/8-Table3-1.png)
Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study](https://www.mdpi.com/jcm/jcm-09-02170/article_deploy/html/images/jcm-09-02170-g001.png)
JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study
![How Will We Interpret Results from the GR-MD- 02 Psoriasis Trial? • NASH & Liver Fibrosis | Galectin Therapeutics How Will We Interpret Results from the GR-MD- 02 Psoriasis Trial? • NASH & Liver Fibrosis | Galectin Therapeutics](http://perspectives.galectintherapeutics.com/wp-content/uploads/2016/04/Screen-Shot-2016-04-28-at-12.16.09-PM-1024x541.png)
How Will We Interpret Results from the GR-MD- 02 Psoriasis Trial? • NASH & Liver Fibrosis | Galectin Therapeutics
![Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab | SpringerLink Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-021-00564-2/MediaObjects/13555_2021_564_Fig3_HTML.png)